JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - GBP (hedged)

WKN A2PR33 | ISIN LU2053354044 |  Fonds
Factsheet
15.04.25
81,50 GBP+2,18 % (+1,74)

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 BE0170813936 KBC Equity Fund Medical Technologies Classic +7,77 % +13,16 % 0,42
2 LU2036818289 CPR Invest - MedTech - H USD - Acc +4,97 % +14,46 % 0,19
3 LU2418149048 UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse F-acc, USD +3,99 % +13,55 % 0,13
4 LU0358044559 UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse Q-acc, USD +3,70 % +13,54 % 0,11
5 LU2194372939 Bellevue Funds (Lux) - Bellevue Medtech & Services U2 USD - Accumulating +3,37 % +14,92 % 0,08
347 LU2053354044 JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - GBP (hedged) -19,62 % +24,33 % -0,90
450 LU1864484214 Candriam Equities L Oncology, C - Capitalisation -16,16 % +14,12 % -1,30
451 IE00BD8GP507 Wellington Global Health Care Equity Fund CHF N AccU -18,33 % +15,47 % -1,33
452 LU2346866317 Candriam Equities L Oncology, N - Capitalisation -16,50 % +14,11 % -1,33
453 AT0000721501 Schoellerbank Global Health Care T -11,95 % +12,08 % -1,18
454 IE00BF2ZTL15 Wellington Global Health Care Equity Fund CHF D AccU -18,83 % +15,46 % -1,36